Skip to main content

Collins John Matthew's Form 4 filing

Calix, Inc (CALX) · filed Oct 30, 2023

Accession no.
0001406666-23-000041
Filed
Oct 30, 2023
Trade date
Oct 27, 2023
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.99M. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Collins John MatthewCIK 0001887165Officer (Chief Commercial Ops Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 27, 2023Common StockMOption exerciseAcquired+15,000$6.95+$104,25015,000Direct
Oct 27, 2023Common StockMOption exerciseAcquired+15,000$8.03+$120,45030,000Direct
Oct 27, 2023Common StockMOption exerciseAcquired+30,000$9.16+$274,80060,000Direct
Oct 27, 2023Common StockSSaleDisposed−60,000$33.14F1−$1,988,4000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 27, 2023Common StockMOption exerciseDisposed−15,000$0.00$020,171Direct
Oct 27, 2023Common StockMOption exerciseDisposed−15,000$0.00$025,000Direct
Oct 27, 2023Common StockMOption exerciseDisposed−30,000$0.00$0165,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Shares sold between $32.39 and $34.12 per share at a weighted average price of $33.14. The reporting person will provide full information regarding the number of shares sold at each sale price upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)